The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Highlights in Heart Failure
Open accessAbstract
Heart failure (HF) remains a major cause of mortality, morbidity, and poor quality of life. It is an area of active research. This article is aimed to give an update on recent advances in all aspects of this syndrome. Major changes occurred in drug treatment of HF with reduced ejection fraction (HFrEF). Sacubitril/valsartan is indicated as a substitute to ACEi/ARBs after PARADIGM-HF (hazard ratio [HR], 0.80; 95% confidence interval [CI], 0.73 to 0.87 for sacubitril/valsartan vs. enalapril for the primary endpoint and Wei, Lin and Weissfeld HR 0.79, 95% CI 0.71–0.89 for recurrent events). Its initiation was then shown as safe and potentially useful in recent studies in patients hospitalized for acute HF. More recently, dapagliflozin and prevention of adverse-outcomes in DAPA-HF trial showed the beneficial effects of the sodium–glucose transporter type 2 inhibitor dapaglifozin vs. placebo, added to optimal standard therapy [HR, 0.74; 95% CI, 0.65 to 0.85;0.74; 95% CI, 0.65 to 0.85 for the primary endpoint]. Trials with other SGLT 2 inhibitors and in other patients, such as those with HF with preserved ejection fraction (HFpEF) or with recent decompensation, are ongoing. Multiple studies showed the unfavourable prognostic significance of abnormalities in serum potassium levels. Potassium lowering agents may allow initiation and titration of mineralocorticoid antagonists in a larger proportion of patients. Meta-analyses suggest better outcomes with ferric carboxymaltose in patients with iron deficiency. Drugs effective in HFrEF may be useful also in HF with mid-range ejection fraction. Better diagnosis and phenotype characterization seem warranted in HF with preserved ejection fraction. These and other burning aspects of HF research are summarized and reviewed in this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–238 of 238
Popović, D., Arena, R. A., & Guazzi, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1140 · Cited by 38
Filippatos, G. S., Birnie, D. H., Gold, M. R., Gerritse, B., Hersi, A. S., Jacobs, S., KUSANO, K. F., Leclercq, C., Müllens, W., & Wilkoff, B. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.895 · Cited by 37
Sharma, A., Al‐Khatib, S. M., Ezekowitz, J. A., Cooper, L. B., Fordyce, C. B., Felker, G. M., Bardy, G. H., Poole, J. E., Bigger, J. T., Buxton, A. E., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1192 · Cited by 35
Gwizdała, A., Rozwadowska, N., Kolanowski, T. J., Malcher, A., Ciepłucha, A., Perek, B., Seniuk, W., Straburzyńska‐Migaj, E., Oko‐Sarnowska, Z., Cholewiński, W., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.700 · Cited by 33
Predictors of Short-Term Clinical Response to Cardiac Resynchronization Therapy
Linde, C. M., Abraham, W. T., Gold, M. R., Daubert, J., Tang, A., Young, J. B., Sherfesee, L., Hudnall, J. H., Fagan, D. H., & Cleland, J. G. F. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.795 · Cited by 33
Packer, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1185 · Cited by 33
Cleland, J. G. F., Teerlink, J. R., Davison, B. A., Shoaib, A., Metra, M., Senger, S., Milo, O., Cotter, G., Bourge, R. C., Parker, J. D., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.786 · Cited by 32
Self-citationFerreira, J. P., Mentz, R. J., Pizard, A., Pitt, B., & Zannad, F. M. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.814 · Cited by 32
Cooper, L. B., Yap, J. J. L., Tay, W. T., Teng, T. K., MacDonald, M. R., Anand, I. S., Sharma, A., O’Connor, C. M., Kraus, W. E., Mentz, R. J., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1223 · Cited by 32
Al-Omary, M. S., Khan, A. A., Davies, A. J., Fletcher, P., McIvor, D., Bastian, B. C., Oldmeadow, C. J., Sverdlov, A. L., Attia, J., & Boyle, A. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12239 · Cited by 30
The Renal–Cardiac Connection in Subjects with Preserved Ejection Fraction: A Population Based Study
Jain, A., Scott, C. G., & Chen, H. H. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12143 · Cited by 29
Martens, P., Verbrugge, F. H., Nijst, P., Dupont, M., & Müllens, W. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.938 · Cited by 29
Feuerstein, A., Bartels, I., Münch, M., Trippel, T. D., Lindhorst, R., Nolte, K., Herrmann‐Lingen, C., Halle, M., Duvinage, A., Düngen, H., et al. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12227 · Cited by 29
McDonald, K., Troughton, R. W., Dahlström, U., Dargie, H., Krum, H., van der Meer, P., McDonagh, T. A., Atherton, J. J., Kupfer, K., George, R. C. S., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1053 · Cited by 29
Laufs, U., Griese‐Mammen, N., Krueger, K., Wachter, A., Anker, S. D., Koehler, F., Rettig‐Ewen, V., Botermann, L., Strauch, D., Trenk, D., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1213 · Cited by 28
Burns, K. V., Gage, R. M., Curtin, A. E., Gorcsan, J., & Bank, A. J. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.906 · Cited by 27
Vaduganathan, M., Cheema, B. S., Cleveland, E., Sankar, K. N., Subacius, H. P., Fonarow, G. C., Solomon, S. D., Lewis, E. F., Greene, S. J., Maggioni, A. P., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.973 · Cited by 27
Nagai, T., Sundaram, V., Shoaib, A., Shiraishi, Y., Kohsaka, S., Rothnie, K., Piper, S. E., McDonagh, T. A., Hardman, S. M. C., Goda, A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1210 · Cited by 27
van der Bijl, P., Khidir, M., Leung, M., Mertens, B. J. A., Marsan, N. A., Delgado, V., & Bax, J. J. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.769 · Cited by 26
Rationale of the FIBROTARGETS Study Designed to Identify Novel Biomarkers of Myocardial Fibrosis
Ferreira, J. P., Machu, J., Girerd, N., Jaisser, F., Thum, T., Butler, J., González, A., Dı́ez, J., Heymans, S. R. B., McDonald, K., et al. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12218 · Cited by 26
Howlett, J. G., Colet, J. C., Dickstein, K., Fuat, A., Pölzl, G., & Delaney, S. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12205 · Cited by 26
Darche, F. F., Baumgärtner, C., Biener, M., Müller‐Hennessen, M., Vafaie, M., Koch, V., Stoyanov, K. M., Rivinius, R., Katus, H. A., & Giannitsis, E. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12150 · Cited by 25
Impaired Renal Function Affects Clinical Outcomes and Management of Patients with Heart Failure
Jenkins, R., Mandarano, L., Gugathas, S., Kaski, J. C., Anderson, L., & Banerjee, D. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12185 · Cited by 25
Cotter, G., Metra, M., Davison, B. A., Jondeau, G., Cleland, J. G. F., Bourge, R. C., Milo, O., O’Connor, C. M., Parker, J. D., Torre‐Amione, G., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.889 · Cited by 25
Self-citationFerreira, J. P., Duarte, K., Pfeffer, M. A., McMurray, J. J. V., Pitt, B., Dickstein, K., Zannad, F. M., Rossignol, P., & Initiative, F. T. H.-R. M. I. D. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1131 · Cited by 25
Kristensen, S. L., Rørth, R., Jhund, P. S., Shen, L., Lee, M. M. Y., Petrie, M. C., Køber, L., & McMurray, J. J. V. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1201 · Cited by 25
Kitai, T., Grodin, J. L., Mentz, R. J., Hernandez, A. F., Butler, J., Metra, M., McMurray, J. J. V., Armstrong, P. W., Starling, R. C., O’Connor, C. M., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.629 · Cited by 24
Self-citationLund, L. H., Svennblad, B., Dahlström, U., & Ståhlberg, M. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.929 · Cited by 24
Butler, J., Vijayakumar, S., & Pitt, B. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1217 · Cited by 23
Felker, G. M., Borentain, M., Cleland, J. G. F., DeSouza, M. M., Kessler, P., O’Connor, C. M., Seiffert, D., Teerlink, J. R., Voors, A. A., & McMurray, J. J. V. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1504 · Cited by 23
QRS Duration Versus Morphology and Survival After Cardiac Resynchronization Therapy
Khidir, M., Delgado, V., Marsan, N. A., Schalij, M. J., & Bax, J. J. (2016) · ESC Heart Failure · doi:10.1002/ehf2.12122 · Cited by 20
Rørth, R., Fosbøl, E. L., Mogensen, U. M., Kragholm, K. H., Numé, A., Gislason, G., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Torp-Pedersen, C. T., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1046 · Cited by 18
Gori, M., Redfield, M. M., Calabrese, A., Canova, P. A., Cioffi, G., Maria, R. D., Grosu, A., Fontana, A., Iacovoni, A., Ferrari, P., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1298 · Cited by 17
Angadi, S. S., Jarrett, C. L., Moustafa, S., Gaesser, G. A., & Mookadam, F. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12149 · Cited by 16
Data and Safety Monitoring Board Evaluation and Management of a Renal Adverse Event Signal in TOPCAT
Bristow, M. R., Sharma, K., Assmann, S. F., Linas, S. L., Gersh, B. J., Grady, C., Rice, M. M., Singh, S. N., Boineau, R., McKinlay, S. M., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.686 · Cited by 15
Sleep-Disordered Breathing in Heart Failure: Facts and Numbers
Pietrock, C., & von Haehling, S. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12193 · Cited by 14
Ezekowitz, J. A., McAlister, F. A., Howlett, J. G., Alemayehu, W. G., Paterson, D. I., Belenkie, I., Oudit, G. Y., Kaul, P., Dyck, J. R. B., & Anderson, T. J. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12200 · Cited by 11
Boriani, G., & Malavasi, V. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.743 · Cited by 9
Metadata
- Authors
- Tomasoni, D., Adamo, M., Lombardi, C. M., & Metra, M.
- Venue
- ESC Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-12-01
- Volume
- 6
- Issue
- 6
- Pages
- 1105-1127
- ISSN
- 2055-5822 (ISSN-L)
- OpenAlex
- W3003995118
- Cited by
- 258
- References
- 238
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.